The TGA is continuing its investigation into issues relating to overseas reports of increased rupture rates of PIP silicone gel-filled breast implants manufactured by Poly Implant Prothèse (PIP) (France). TGA has reviewed all reports of failure in Australia of this product. The rate of reported failures appears to be within industry norms for this type of product and the rupture rate for these implants in Australia is not reflective of the overseas rupture rate. The TGA is also awaiting results from tests being conducted on the implants.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.